These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16885126)

  • 21. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets.
    Cuppok Y; Muschert S; Marucci M; Hjaertstam J; Siepmann F; Axelsson A; Siepmann J
    Int J Pharm; 2011 May; 409(1-2):30-7. PubMed ID: 21354465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of grafted thermosensitive hydrogels for heating activated controlled release.
    Ankareddi I; Brazel CS
    Int J Pharm; 2007 May; 336(2):241-7. PubMed ID: 17234371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a new controlled-drug delivery concept based on the use of thermoresponsive polymers.
    Eeckman F; Moës AJ; Amighi K
    Int J Pharm; 2002 Jul; 241(1):113-25. PubMed ID: 12086727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
    Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
    Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New film forming emulsions containing Eudragit® NE and/or RS 30D for sustained dermal delivery of nonivamide.
    Lunter DJ; Daniels R
    Eur J Pharm Biopharm; 2012 Oct; 82(2):291-8. PubMed ID: 22750130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
    Khan MZ; Prebeg Z; Kurjaković N
    J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
    Boyapally H; Nukala RK; Douroumis D
    Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
    Sungthongjeen S; Paeratakul O; Limmatvapirat S; Puttipipatkhachorn S
    Int J Pharm; 2006 Nov; 324(2):136-43. PubMed ID: 16828997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential intracellular release of water-soluble cargos from Shell-crosslinked polymersomes.
    Du F; Bobbala S; Yi S; Scott EA
    J Control Release; 2018 Jul; 282():90-100. PubMed ID: 29601932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane.
    Hung SF; Hsieh CM; Chen YC; Lin CM; Ho HO; Sheu MT
    Int J Pharm; 2015 Mar; 480(1-2):15-26. PubMed ID: 25575473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release behavior of bioactive agents from pH-sensitive hydrogels.
    Khare AR; Peppas NA
    J Biomater Sci Polym Ed; 1993; 4(3):275-89. PubMed ID: 8476795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new drug delivery system using plasma-irradiated pharmaceutical aids. VI. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of water-soluble polymers as a wall material.
    Kuzuya M; Ishikawa M; Noguchi T; Niwa J; Kondo S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):192-5. PubMed ID: 8582038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.